Mirae Asset Global Investments Co. Ltd. Makes New Investment in CVS Health Corporation $CVS

Mirae Asset Global Investments Co. Ltd. bought a new position in shares of CVS Health Corporation (NYSE:CVS) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 385,328 shares of the pharmacy operator’s stock, valued at approximately $33,019,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Kilter Group LLC acquired a new position in CVS Health during the 2nd quarter worth approximately $27,000. J.Safra Asset Management Corp acquired a new stake in shares of CVS Health during the 2nd quarter valued at approximately $30,000. Beaird Harris Wealth Management LLC grew its position in shares of CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 195 shares during the last quarter. Timbuktu Capital Management LLC purchased a new position in CVS Health in the 2nd quarter valued at about $31,000. Finally, Dunhill Financial LLC acquired a new stake in shares of CVS Health during the second quarter worth $32,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: One valuation analysis says CVS could be approximately 27% undervalued, with the next earnings report providing a potential catalyst. Analysts reportedly expect quarterly earnings of about $1.62 per share, making segment performance and management commentary important for the shares. CVS Health Could Be 27% Undervalued As Earnings Focus Sharpens
• Positive Sentiment: CVS’s free Project Health screenings, which do not require appointments or insurance, support the company’s community-health strategy and could strengthen patient engagement and brand visibility. The immediate financial impact is likely limited. CVS Health Project Health Screenings
• Neutral Sentiment: Articles highlight CVS’s broader strategy of combining healthcare services with housing and other social-support initiatives. The approach may improve long-term outcomes and customer retention, but near-term earnings effects are unclear. CVS Health Beyond Housing
• Neutral Sentiment: Analyst-estimate and ratings coverage provides context ahead of earnings but does not identify a clear change in consensus or a new company-specific catalyst. CVS Health Stock Analyst Estimates and Ratings
• Negative Sentiment: The University of Kentucky and five other hospital systems are suing CVS over alleged fraud or prescription-contract breaches. The claims, including a reported $41 million UK lawsuit, create litigation, reimbursement, and reputational risks, although the allegations have not been proven. Hospital Systems Sue CVS UK Sues CVS Health
• Negative Sentiment: CVS reportedly faces as much as $2 billion of Medicare ratings-related risk. Any reduction in Medicare Advantage star ratings could hurt bonus payments, membership economics, and expectations for future earnings. CVS Health Medicare Ratings Risk

CVS Health Stock Down 0.1%

NYSE:CVS opened at $90.20 on Monday. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. The stock has a 50 day moving average of $91.22 and a 200-day moving average of $88.76. The firm has a market capitalization of $115.36 billion, a PE ratio of 23.86, a price-to-earnings-growth ratio of 0.84 and a beta of 0.58. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. CVS Health’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same period last year, the firm posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Analysts predict that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Investors of record on Thursday, October 22nd will be issued a dividend of $0.6650 per share. This represents a $2.66 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Thursday, October 22nd. CVS Health’s payout ratio is presently 70.37%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on CVS. Sanford C. Bernstein reissued an “outperform” rating and set a $112.00 price target on shares of CVS Health in a research report on Wednesday, September 9th. Argus raised their price objective on CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a report on Wednesday, August 19th. Weiss Ratings lowered CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, October 9th. Wall Street Zen lowered CVS Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 19th. Finally, HSBC reiterated a “hold” rating and set a $103.00 target price on shares of CVS Health in a report on Monday, July 6th. Nineteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $109.64.

CVS Health Profile

CVS Health Corporation (NYSE: CVS) is a diversified health care company that provides pharmacy, insurance and health services in the United States. Its businesses serve consumers, employers, health plans and health care providers through pharmacies, benefit programs, insurance coverage and clinical care services.

The company’s Pharmacy Services segment, led by CVS Caremark, manages prescription drug benefits for employers, insurers and government programs. CVS Pharmacy operates retail pharmacies and health-focused stores that dispense prescriptions and offer over-the-counter products, health and wellness merchandise, immunizations and related services.